<DOC>
	<DOCNO>NCT02809989</DOCNO>
	<brief_summary>The aim non-interventional study extend knowledge effectiveness Ovaleap® ( number oocytes pregnancy rate ) routine IVF- ICSI-treatment use Gonadotropin-releasing hormone ( GnRH ) antagonist protocol large number patient .</brief_summary>
	<brief_title>A Study Evaluate Effect Ovaleap® Pregnancy Rate Clinical Effects Well User-friendliness Ovaleap®-Pen .</brief_title>
	<detailed_description />
	<criteria>Women medical indication ovarian stimulation therapy purpose IVF ICSI . Firsttime ovarian stimulate therapy IVF ICSI . Ovarian stimulation therapy exclusively Ovaleap® . GnRH antagonist protocol . BodyMassIndex ( BMI ) &lt; 30 kg/m2 . Duration menstrual cycle 24 35 day . Additional criterion apply , please contact investigator information Combined application IVF ICSI Ovarian hyperstimulation Ovaleap® consecutive `` social freezing '' . Polycystic ovary syndrome ( PCOS ) . Endometriosis ( AFS ( American Fertility Society ) grade 3 4 ) . Uterine myoma ( intramural &gt; 4 cm , submucosal ) . Hydrosalpinx ( one side side ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>